Form 4 for LAZ Lazard, Inc.
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-13 · accession 0001628280-25-013284 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-17 | 2025-03-13 | LAZ | Orszag Peter Richard | CEO, COB, Dir | M - OptEx | — | +258.2K | 376.8K | +218% | — |
| DM | 2025-03-17 | 2025-03-14+ | LAZ | Orszag Peter Richard | CEO, COB, Dir | S - Sale+OE | $45.40 | -129.1K | 170.3K | -43% | -$5.86M |
| D | 2025-03-17 | 2025-03-13 | LAZ | Orszag Peter Richard | CEO, COB, Dir | D - Sale to Iss | $45.09 | -77.4K | 299.4K | -21% | -$3.49M |
| D | 2025-03-17 | 2025-03-14 | LAZ | Orszag Peter Richard | CEO, COB, Dir | A - Grant | — | +168.2K | 306.5K | +122% | — |
| D | 2025-03-17 | 2025-03-13 | LAZ | Orszag Peter Richard | CEO, COB, Dir | M - OptEx | — | -258.2K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-13 | M | A | 258,154 | — | 376,809 | D | — | — | (F1) Shares of Common Stock were acquired upon the exchange of the Performance-based Restricted Participation Units ("PRPUs") referenced in Footnote (10). (F2) Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person. |
| 2 | Common | Common Stock | 2025-03-14 | S | D | 27,208 | $44.87 | 272,155 | D | — | — | (F5) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures. (F6) The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $44.31 to $45.31 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. (F2) Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person. |
| 3 | Common | Common Stock | 2025-03-14 | S | D | 37,331 | $45.51 | 234,824 | D | — | — | (F5) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures. (F7) The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $45.32 to $45.87 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. (F2) Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person. |
| 4 | Common | Common Stock | 2025-03-17 | S | D | 38,187 | $45.31 | 196,637 | D | — | — | (F5) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures. (F8) The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $44.80 to $45.80, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. (F2) Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person. |
| 5 | Common | Common Stock | 2025-03-17 | S | D | 26,352 | $45.91 | 170,285 | D | — | — | (F5) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures. (F9) The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $45.81 to $46.11, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. (F2) Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person. |
| 6 | Common | Common Stock | 2025-03-13 | D | D | 77,446 | $45.09 | 299,363 | D | — | — | (F3) Represents shares of Common Stock sold to the Company to cover estimated taxes arising from the exchange of PRPUs referenced in Footnote (10). (F4) Represents the average of the high and low price of Common Stock on the New York Stock Exchange on the date of the exchange of the PRPUs referenced in Footnote (10). (F2) Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person. |
| 7 | Derivative | Restricted Participation Units | 2025-03-14 | A | A | 168,206 | — | 306,546 | D | — · — to — | 168,206 Common Stock | (F14) Each RPU represents an interest in Lazard Group LLC that has satisfied its minimum value condition and that may be exchanged for one share of Common Stock. (F12) Amount excludes a prior grant of 1,250,000 Stock Price Performance-based Restricted Participation Units, which was reflected in the Company's proxy statement for the relevant year. (F13) These Restricted Participation Units ("RPUs") will vest on or around March 15, 2027. |
| 8 | Derivative | Performance-based Restricted Participation Units | 2025-03-13 | M | D | 258,154 | — | 0 | D | — · — to — | 258,154 Common Stock | (F10) Represents a prior grant of PRPUs awarded with respect to compensation for 2021 of which performance and other conditions have been satisfied. The grant at target was reflected in the Company's proxy statement for the relevant year. (F11) Each PRPU (the performance and other conditions of which have been satisfied) represents an interest in Lazard Group LLC that may be exchanged for one share of Common Stock. (F12) Amount excludes a prior grant of 1,250,000 Stock Price Performance-based Restricted Participation Units, which was reflected in the Company's proxy statement for the relevant year. (F1) Shares of Common Stock were acquired upon the exchange of the Performance-based Restricted Participation Units ("PRPUs") referenced in Footnote (10). |